Trial site
Imperial College Healthcare Nhs Trust - Hammersmith Hospital
- 18running trials
- 8closed trials
The trials here
What the 26 trials at this site are about, from their registry records.
- Conditions
- Ovarian cancer5 trials
- Pancreatic cancer4 trials
- Thalassaemia4 trials
- Liver and biliary tract cancer3 trials
- Bladder cancer2 trials
- Colorectal cancer2 trials
- Head and neck cancer2 trials
- Heart failure2 trials
- Kidney cancer2 trials
- Lung cancer2 trials
- Myeloproliferative neoplasms2 trials
- Sickle cell disease2 trials
- and 12 more
- Phase
- Phase 38 trials
- Phase 25 trials
- Phase 14 trials
- Phase 2/33 trials
- Phase 1/21 trial
- Status
- Active, not recruiting12 trials
- Recruiting6 trials
- Completed5 trials
- Terminated3 trials
- Lead sponsor
- Incyte Corporation4 trials
- Agios Pharmaceuticals, Inc.3 trials
- Medtronic3 trials
- Vertex Pharmaceuticals Incorporated3 trials
- AVEO Pharmaceuticals, Inc.1 trial
- and 12 more
Running trials
Recruiting
Recruiting
Study of REGN13335 in Adult Participants With Pulmonary Arterial Hypertension (PAH)
Recruiting
Inobrodib, Pomalidomide and Dexamethasone in Relapsed or Refractory Multiple Myeloma
Recruiting
Recruiting
Recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Phase 3 Study of Pelabresib (CPI-0610) in Myelofibrosis (MF) (MANIFEST-2)
Active, not recruiting
Personalized Therapy Study - HFRS (TriageHF) Post Approval Study
Active, not recruiting
Personalized Therapy Study - Intrinsic Antitachycardia Pacing Post-Approval Study (iATP PAS)
Active, not recruiting
Active, not recruiting
Active, not recruiting
Personalized Therapy Study - Attain Stability Quad Post-Approval Study
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Ovarian cancer2 recruiting
- High blood pressure1 recruiting
- Multiple myeloma1 recruiting
- Pulmonary arterial hypertension1 recruiting
Closed trials
Completed
Terminated
Completed
Terminated
Completed
INCB106385 Alone or in Combination With Immunotherapy in Advanced Solid Tumors
Completed
A Safety and Efficacy Study Evaluating CTX001 in Subjects With Severe Sickle Cell Disease
Completed
Terminated
Site data: ClinicalTrials.govUpdated 19 Nov 2026